Covered recipient · General Payments record
SELENE ZAMARRIPA
Eye and Vision Services Providers Optometrist
General Payments · PY2021–2024
$1,438.86
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $422.95 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $221.95 | 10 |
| Amgen Inc. | $134.94 | 5 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.53 | 1 |
| Harrow Eye, LLC | $23.27 | 1 |
| Bausch & Lomb Americas Inc. | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.37 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389818 | CMS |
| ABBVIE INC. | $27.12 | 01/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389820 | CMS |
| ABBVIE INC. | $27.68 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389822 | CMS |
| ABBVIE INC. | $22.64 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389824 | CMS |
| ABBVIE INC. | $22.86 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389826 | CMS |
| ABBVIE INC. | $18.53 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389828 | CMS |
| ABBVIE INC. | $22.36 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389830 | CMS |
| ABBVIE INC. | $28.98 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389832 | CMS |
| ABBVIE INC. | $19.18 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389834 | CMS |
| ABBVIE INC. | $10.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106389836 | CMS |
| Amgen Inc. | $30.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221853 | CMS |
| Amgen Inc. | $30.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221857 | CMS |
| Amgen Inc. | $30.00 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221860 | CMS |
| Amgen Inc. | $20.75 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221845 | CMS |
| Amgen Inc. | $24.19 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221848 | CMS |
| Bausch & Lomb Americas Inc. | $14.26 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140446756 | CMS |
| Harrow Eye, LLC | $23.27 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145623483 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.53 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152201171 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.